|Day Low/High||0.81 / 0.86|
|52 Wk Low/High||0.84 / 4.32|
TheStreet's biotech columnist offers his own report card on biotech stocks.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Ampio Pharmaceuticals Inc , where a total of 1,453 contracts have traded so far, representing approximately 145,300 underlying shares. That amounts to about 81.2% of AMPE's average daily trading volume over the past month of 179,045 shares.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Trade-Ideas LLC identified Ampio Pharmaceuticals (AMPE) as a weak on high relative volume candidate
Ampio Pharma (AMPE) stock is sharply lower this afternoon following a phase 3 trial for its osteoarthritis pain treatment.
Ampio to request approval from the FDA for the treatment of pain due to severe osteoarthritis of the knee.
Aytu and Ampio to Host Joint Webcast and Conference Call Today at 4:15 PM EST